Thread by @ddayen

I forgot to keep up with the Donna Shalala stock disclosure situation but this is a delicious end to this story.
Here's where we left off: prospect.org/coronavirus/un…

This was based on an analysis of Shalala's reported stock sales, which didn't cover all the stocks she had. Among a few others, I cited TEGNA, Lennar, Teva Pharmaceuticals, and Watsco.

I have to burn the source because he lied to me: Shalala's press person Carlos Condarco called me that morning furious, saying there were innocent explanations for all of these trades, and how could I post that without waiting for a response (I'd contacted them 18 hours earlier)

The date of that story was May 2.
On May 15, Shalala released another periodic transaction report, which announced more sales. Roll Call wrote it up a couple weeks later. rollcall.com/2020/05/29/cam…

Here is that report. The stocks she sold:
TEGNA, Lennar, Teva Pharmaceuticals, and Watsco.
All of this was done AFTER my May 2 report. The sales were made mostly on May 7. clerk.house.gov/public_disc/pt…

Here's Condarco, the spokesperson, telling Roll Call how "urgent" it was to get these stocks sold. Not so urgent that they could finish a job until a report identified the stocks that were remaining.

So Shalala's spokesperson tried to bully me and claim I was incorrect in my reporting, when behind the scenes Team Shalala was madly trying to sell the exact stocks I identified.

This is all normal bullshit a reporter goes through and I don't really care. But as I said on May 2, "If [Shalala] or her office cannot manage to properly list her own stock history... she has no business as part of any oversight entity." Lying about that history, also bad.

This of course would be much worse if there were actually a chair of the bailout oversight panel on which Shalala serves, 76 days after it was established. prospect.org/coronavirus/un…